CIDRAP newsletters options
Through Sep 24, the CDC says, seroprevalence rates ranged from 0% to 23%.
While both North America and Europe have detected chronic wasting disease (CWD) in cervids such as deer, the two continental strains are distinct, reports a study yesterday in Proceedings of the National Academy of Sciences (PNAS).
A study of SARS-CoV-2–positive Canadian children in CMAJ yesterday showed that 64.1% of children were symptomatic, with loss of taste or smell, stomach upset, headache, and fever most predictive of infection.
The number of drug suppliers able to deliver at least 80% of their products on time dropped 16 percentage points.
States that took aggressive steps are seeing results, White House experts say.
The artificial intelligence platform detected COVID-19 10 times faster and was a bit more accurate.
A PLOS One study yesterday showed a 43% overall mortality rate for mechanically ventilated COVID-19 patients, with an even higher risk of death for patients of advanced age.
Chronic wasting disease (CWD), a fatal neurologic prion disease that affects members of the deer family, was detected in two cervids in Montana and Virginia. In 2019, 144 cases of CWD were reported in Montana and 1 case was reported in Virginia.
One expert says Europe could experience a third wave if it repeats mistakes it made after the first wave.
Racial minorities and other at-risk children appear to have more serious outcomes.
Combined data show 70% efficacy, but it was 90% when the first dose was halved.
The biggest concern is what Thanksgiving gatherings will mean for hospitals, some of which are already buckling.
The report details obstacles for more than 12 million English language learners and special education students.
An antibiotic stewardship intervention implemented at four regional hospitals in Denmark was associated with significantly lower overall antibiotic exposure for patients who had community acquired pneumonia (CAP) and a higher likelihood of patients being treated with recommended antibiotics, Danish researchers reported late last week in the International Journal of Infectious Diseases.
A Dutch study late last week found reduced lung capacity in 42% of COVID-19 patients 3 months after recovery, with many patients reporting severe problems with fatigue, functional impairment, and quality of life (QoL).
The One Health Global Leaders Group fulfills a request of the UN secretary-general.
Also, Pfizer and BioNTech submitted an EUA request for their vaccine, offering hope it will be available this year.
The findings may explain why COVID-19 spreads quickly and is difficult to contain.
A study yesterday found that 47% of COVID-19 patients who required prolonged mechanical ventilation developed potentially life-threatening tracheal (airway) complications.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Nov 19
